GSK’s (GSK) older adult RSV vaccine candidate contains Agenus’ (AGEN) QS-21 STIMULON.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on AGEN:
- Agenus to present Phase 1, Phase 2 trial data at ASCO meeting
- B. Riley came away ‘encouraged’ on Agenus after AACR
- Agenus receives Fast Track Designation from FDA for botensilimab, balstilimab
- Agenus announces results from cohort in study of botensilimab with balstilimab
- Agenus announces 2023 catalysts, objectives
Questions or Comments about the article? Write to editor@tipranks.com